Antiphospholipid syndrome accompanied by a silent splenic infarct in a patient with juvenile SLE.
Constantin
Tamás
T
Ponyi
Andrea
A
Varga
Edit
E
Dankó
Katalin
K
Fekete
György
G
Kovács
Gábor
G
D017153:Antibodies, Anticardiolipin / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000276:immunology*; D002648:Child; D003374:Coumarins / Q000627:therapeutic use; D005260:Female; D006023:Glycoproteins / Q000097:blood; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D012016:Reference Values; D013159:Splenic Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014463:Ultrasonography
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D003374:Coumarins; D006023:Glycoproteins; D007075:Immunoglobulin M; D016682:Lupus Coagulation Inhibitor; D006493:Heparin; C030123:coumarin